Purchase Order 75D30118P03059

The National Institutes of Health, under the National Center for Advancing Translational Sciences, awarded a $1.94 million firm-fixed price purchase order to Celltrio Inc. to deliver a CellTrio Cell Line Automation System with installation and a 12-month warranty. The system, which includes an incubator, sample storage and retrieval system, microscope, cell counter, robotic handling, centrifuge, and integrated liquid handler and software, will support automated cell culture processes in NIH's...

This is a firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian federal agency, to Capital Biosciences, Inc. for "CUSTOM CELL IMMORTALIZATION FOR MARVIN GERSHENGORN, QUOTE: 9429". The contract has a ceiling value of $13,445.00 and an ultimate completion date of October 1, 2010. There is no set-aside designation for this award. The contract provides for the delivery of custom cell immortalization services to...

This federal contract award, valued at $248,779.00, was issued by the Centers for Disease Control and Prevention (CDC) to Bioreliance Corporation, a foreign-owned, for-profit organization, to conduct follow-up testing for tumorigenicity and oncogenicity on the Master Cell Bank (MCB) of Expi293F cells. The contract is a firm-fixed-price purchase order with a completion date of September 24, 2026. The original sources sought notice indicates that the CDC Influenza Division requires cGMP-grade cell...

The U.S. Food and Drug Administration (FDA) awarded a Firm Fixed Price Purchase Order contract worth $94,003.45 to Charles River Laboratories Cell Solutions, Inc. for the provision of human primary CD34+ hematopoietic stem and progenitor cells. This contract supports the FDA's Center for Biologics Evaluation and Research (CBER), Division of Cell and Gene Therapy (DCGT) in conducting critical path research to develop and promote technology for the regulation of cellular and genetic...

Revvity Signals Software, Inc. Informatics Division, a subsidiary of Revvity Inc. Medical Imaging, LLC, has been awarded a $93,652 firm fixed price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to provide a Celleca PLX Image Cytometer in support of the Stem Cell Translation Laboratory. The solicitation sought to advance stem cell technologies for clinical application, drug discovery, and regenerative medicine through the...

This is a firm-fixed price purchase order awarded by the Department of Health and Human Services' National Cancer Institute (NCI) to Nexcelom Bioscience LLC, a small business, for a Celigo Image Cytometer System. The $159,000 contract supports the NCI's Transplantation Therapy Section within the Experimental Transplantation and Immunology Branch, which focuses on research related to T cell homeostasis, repertoire, function, and regeneration in a transplantation setting. The Celigo system will...

This federal contract award with ID 75N90019P00629 was issued by the National Institutes of Health (NIH) Clinical Center to Cell Line Genetics, Inc. for $11,200.00. The contract is for a firm fixed-price purchase order with a performance period ending on June 30, 2020. The contract was not set aside for any special type of business. Cell Line Genetics, Inc. is a for-profit organization that is minority-owned, woman-owned, and Hispanic American-owned. This award appears to be related to a...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $231,000.00 firm-fixed-price purchase order to Life Technologies Corporation, a for-profit manufacturer, for the provision of EXPI293F license and cell lines. This contract does not have a set-aside designation. The products and services are to be delivered by the July 31, 2021 completion date. Life Technologies Corporation is a subsidiary of the parent company Thermo Electron Corporation, which...

The Centers for Disease Control and Prevention (CDC) awarded a $249,662 purchase order to Cell Microsystems Inc. to procure cell lines in support of the agency's biomedical research and public health initiatives. The firm fixed price contract has a period of performance from September 11, 2023 through October 30, 2023 for delivery of the requested cell lines to CDC facilities in Durham, North Carolina. No subcontractors or set aside designations were identified. This award advances the CDC's...

This federal contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Cellecta, Inc., a for-profit manufacturer of genomic research products and services. The $299,952 firm-fixed price contract is for "GENETIC ANALYSIS OF CTCS AT THE SINGLE-CELL LEVEL" and does not have a set-aside designation. Cellecta specializes in providing advanced genomic technologies, including CRISPR, RNAi, and other tools, to support biomedical research...